Search Results - "Clinical rheumatology"

Refine Results
  1. 1

    Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment by Soy, Mehmet, Keser, Gökhan, Atagündüz, Pamir, Tabak, Fehmi, Atagündüz, Işık, Kayhan, Servet

    Published in Clinical rheumatology (01-07-2020)
    “…COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild symptoms in the majority of the cases, while immunologic…”
    Get full text
    Journal Article
  2. 2

    Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets by Misra, Durga Prasanna, Agarwal, Vikas, Gasparyan, Armen Yuri, Zimba, Olena

    Published in Clinical rheumatology (01-07-2020)
    “…The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global…”
    Get full text
    Journal Article
  3. 3

    Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad by Ahmed, Sakir, Zimba, Olena, Gasparyan, Armen Yuri

    Published in Clinical rheumatology (01-09-2020)
    “…The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being comprehended. A high number of thrombotic episodes are reported, along with the…”
    Get full text
    Journal Article
  4. 4

    Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? by Jara, Luis J., Vera-Lastra, Olga, Mahroum, Naim, Pineda, Carlos, Shoenfeld, Yehuda

    Published in Clinical rheumatology (01-05-2022)
    “…To date, around 60% of the world population has been protected by vaccines against SARS-CoV-2, significantly reducing the devastating effect of the pandemic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Vasculitis associated with immune checkpoint inhibitors—a systematic review by Daxini, Anisha, Cronin, Keri, Sreih, Antoine G.

    Published in Clinical rheumatology (01-09-2018)
    “…Recent experimental and genetic studies have implicated the role of programmed cell death protein 1 (PD-1), programmed cell death protein-ligand 1 (PDL-1), and…”
    Get full text
    Journal Article
  7. 7

    Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months by Karaarslan, Fatih, Güneri, Fulya Demircioğlu, Kardeş, Sinan

    Published in Clinical rheumatology (01-01-2022)
    “…Objective To document the detailed characteristics including severity, type, and locations of rheumatic and musculoskeletal symptoms along with other COVID-19…”
    Get full text
    Journal Article
  8. 8

    Post-COVID-19 arthritis: a case report and literature review by Gasparotto, M., Framba, V., Piovella, C., Doria, A., Iaccarino, Luca

    Published in Clinical rheumatology (01-08-2021)
    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers…”
    Get full text
    Journal Article
  9. 9

    JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis by Miserocchi, Elisabetta, Giuffrè, Chiara, Cornalba, Martina, Pontikaki, Irene, Cimaz, Rolando

    Published in Clinical rheumatology (01-03-2020)
    “…To present our preliminary experience with JAK inhibitors in treating patients affected by juvenile idiopathic arthritis (JIA) and associated uveitis. Case…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology by Mantovani Cardoso, Eduardo, Hundal, Jasmin, Feterman, Dominique, Magaldi, John

    Published in Clinical rheumatology (01-09-2020)
    “…In the midst of the COVID-19 pandemic, further understanding of its complications points towards dysregulated immune response as a major component. Systemic…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis by Misra, Durga Prasanna, Rathore, Upendra, Patro, Pallavi, Agarwal, Vikas, Sharma, Aman

    Published in Clinical rheumatology (01-11-2021)
    “…The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area. A systematic review of Scopus, Web of…”
    Get full text
    Journal Article
  14. 14

    Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India by Shenoy, Padmanabha, Ahmed, Sakir, Paul, Aby, Skaria, Teny Grace, Joby, Joel, Alias, Bazil

    Published in Clinical rheumatology (01-09-2020)
    “…The emergent COVID-19 pandemic dictates an urgent switch to teleconsultation. India has high patient to rheumatologist ratio, and patients have limited…”
    Get full text
    Journal Article
  15. 15

    Determinants of COVID-19 disease severity in patients with underlying rheumatic disease by Santos, C. Sieiro, Morales, C. Moriano, Álvarez, E. Díez, Castro, C. Álvarez, Robles, A. López, Sandoval, T. Perez

    Published in Clinical rheumatology (01-09-2020)
    “…Background Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd…”
    Get full text
    Journal Article
  16. 16

    Ankylosing spondylitis risk factors: a systematic literature review by Hwang, Mark C., Ridley, Lauren, Reveille, John D.

    Published in Clinical rheumatology (01-08-2021)
    “…Radiographic axial spondyloarthritis (also known as ankylosing spondylitis [AS]) is a chronic immune-mediated arthritis characterized by inflammation of the…”
    Get full text
    Journal Article
  17. 17

    Haemophagocytic syndrome and COVID-19 by Retamozo, Soledad, Brito-Zerón, Pilar, Sisó-Almirall, Antoni, Flores-Chávez, Alejandra, Soto-Cárdenas, María-José, Ramos-Casals, Manuel

    Published in Clinical rheumatology (01-04-2021)
    “…Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic hyperinflammatory syndromes with a common terminal pathway triggered by…”
    Get full text
    Journal Article
  18. 18

    Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample by Kim, Yunkyung, Kang, Jihun, Kim, Geun-Tae

    Published in Clinical rheumatology (01-09-2018)
    “…Hyperuricemia is not only a risk factor for gout but also an independent determinant of hypertension, diabetes, and chronic kidney diseases. Although the…”
    Get full text
    Journal Article
  19. 19

    A comprehensive review of rituximab therapy in rheumatoid arthritis patients by Tavakolpour, Soheil, Alesaeidi, Samira, Darvishi, Mohammad, GhasemiAdl, Mojtaba, Darabi-Monadi, Sahar, Akhlaghdoust, Meisam, Elikaei Behjati, Somayeh, Jafarieh, Arash

    Published in Clinical rheumatology (01-11-2019)
    “…Rituximab (RTX) is an approved treatment for rheumatoid arthritis (RA) patients that do not respond adequately to disease-modifying antirheumatic drugs…”
    Get full text
    Journal Article
  20. 20